FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer

NCT04174352 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

ERα+ Breast Cancer
ESR1 Gene Mutation

Interventions

DRUG: Tamoxifen
DIAGNOSTIC_TEST: FES PET/CT

Sponsor

University of Wisconsin, Madison